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The government plans to continue using NHS funds to contract with commercial healthcare providers 
in the second phase of the independent sector treatment centre programme, but Allyson M Pollock 
and Sylvia Godden argue that no good evidence is available to support this policy
Independent sector treatment centres: 
evidence so far
The policy of the Department of Health in England 
is to use NHS funds to contract with for-profit multi-
national healthcare corporations to deliver clinical 
services. One controversial aspect of this policy is 
the independent sector treatment centre programme, 
which over the course of two phases (waves) will pro-
vide elective surgery and other services at a total cost 
of over £5bn (€6.7bn; $9.7bn). The announcement 
by the secretary of state for health, Alan Johnson—
that new contracts will be determined by local com-
missioners but second phase schemes will go ahead 
if they are value for money—makes a review of the 
evidence to support the policy timely.1-3 This article 
assesses the programme in terms of the objectives 
set by the Department of Health4—that these centres 
should provide:
High productivity• 
High quality health care• 
An increase in the number of  medical professionals • 
working in England (staff  will come from overseas 
or be additional to the existing NHS workforce)
Good value for money.• 
History of the independent sector treatment centre 
market
The initiative was presented as a way to provide extra 
capacity to the NHS and reduce waiting times for 
elective surgery. The programme currently has two 
waves. The first wave, launched in 2003 was con-
tracted to deliver up to 170 000 finished consultant 
episodes annually over five years, at a cost of £1.6bn. 
The second phase, launched in March 2005, should 
provide up to 250 000 additional elective and two mil-
lion extra diagnostic procedures annually, over five 
years, at an estimated cost of around £4bn (£3bn 
for elective procedures and £1bn for diagnostics).5 
In July 2007, 24 centres, provided by seven for-profit 
companies, were operational.6 
Evidence on productivity
In addition to cost data, evaluations of productivity 
in the NHS rely on two key sources—bed data and 
admissions data.
Bed data
Data on the number of available and occupied beds 
are collected annually from NHS trusts, but no such 
data are collected from independent sector treatment 
centres, although government policy is that they 
should be submitted as part of hospital episode sta-
tistics. Without these data it is impossible to assess 
the contribution that these centres make to capacity, 
productivity, or efficiency as extra beds, throughput, 
and bed occupancy cannot be measured.
Current government policy may be to substitute 
beds from the private sector rather than to provide 
extra capacity within the NHS. Overall, NHS capacity 
is decreasing, with a fall in the average daily number 
of available beds in NHS hospitals in England (includ-
ing day beds) of over 23 000 (figure) between 1997 
and 2006-7.
admissions data
The NHS in England requires all providers to make a 
data return on each patient. These returns are used to 
derive hospital episode statistics. They contain infor-
mation such as diagnosis and procedure, age, sex, and 
residence, date of admission and discharge, and where 
treatment took place.
Although independent sector treatment centres are 
required to submit hospital episode statistics returns, 
data from these centres are not of comparable quality 
to those from the NHS, and the returns provide no 
comprehensive account of admissions and procedures 
undertaken. The Health Care Commission found that, 
of those independent centres submitting data for the 
period April to December 2006, 59% of episodes had 
no diagnosis, 18% had no procedure code, 60% had no 
pricing information (healthcare resource group), and 
83% had not been assigned an ethnicity category. It 
also found that outpatient data from independent sec-
tor treatment centres were under-reported  compared 
Average daily number of available beds in NHS hospitals, by sector, 
England, 1987-8 to 2006-7. Taken from Department of Health, 
Hospital Activity Statistics, form KH03
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with outpatient data from the NHS.6 7 Incomplete and 
poor quality hospital episode statistics data limited 
the commission’s ability to assess quality of care in 
centres.6 
Evidence on quality of health care
Measures of quality and performance—including 
readmission rates within 28 days, revision rates, 
 perioperative mortality, and length of stay—all rely on 
hospital episode statistics data. Independent centres, 
however, have not been routinely providing good qual-
ity and complete data. 
As part of the commercial contracting process the 
Department of Health Commercial Directorate estab-
lished a separate reporting system for independent 
sector treatment centres based on 26 unpublished key 
performance indicators, around eight of which are clini-
cal, but even these indicators are of variable quality. 
The first research on the quality of work undertaken 
by private centres was carried out by the National 
Centre for Health Outcomes Development on four 
schemes (five providers) on the basis of the key per-
formance indicator returns. Its report, published in 
October 2005, stated that data were so variable in 
quality and so incomplete as to render “any attempt 
at commenting on trends and comparisons between 
schemes and with any external benchmarks, futile.”8 
The absence of systematic data about quality height-
ens concerns about standards of care. The House of 
Commons Health Committee in 2006 heard evidence 
suggesting that some independent centres offered seri-
ously substandard care.9 Professional bodies and asso-
ciations had reported problems, including the use of 
foreign trained doctors unfamiliar with NHS surgical 
techniques, lax standards of vetting and training, lack 
of continuity of care, and a large number of pend-
ing litigation cases. The Royal College of Surgeons 
of England reported “increasing evidence” that these 
centres were unable to manage complications “with 
consequent transfer to existing NHS facilities and on 
occasions to the consultant to whom the patient was 
initially referred.”9 The president of the British Ortho-
paedic Association submitted two dossiers of cases 
causing concern to the Department of Health, but lack 
of comparable routine data allowed the department to 
ignore the findings.10 
Evidence on increases in clinical staff 
A key concern was that independent sector treatment 
centres should not employ existing NHS workers but 
should take on new staff. The additionality policy 
stated that private centres could not employ clinical 
staff who had worked in the NHS within the previous 
six months.11 Exemptions were allowed under excep-
tional circumstances only. The policy of additionality 
has now been all but abandoned by the government, 
however, so that NHS employees who are not in 
“shortage professions” can be employed by private 
centres and NHS trusts can renegotiate contracts to 
allow staff to work in the private sector for some of 
their hours. Shortage professions have been redefined 
so that most NHS staff are now eligible to work in pri-
vate centres,12 and even those in shortage specialties 
can work during “non-contracted hours.”13 
Workforce returns are made by the NHS to the Infor-
mation Centre for Health and Social Care. We asked 
for similar data on the independent sector and were 
told that they are not collected at the moment, although 
this may happen soon.14 The Commercial Directorate 
established new contracts last year, which require that 
workforce reports are collected from private centres.
A response to a freedom of information request in 
February 2007 indicated that around a quarter of full 
time clinical staff (doctors, nurses, and allied health 
professionals) working in private centres had been sec-
onded from NHS trusts.15 These numbers are likely 
to grow, as a leaked report forecast that the NHS was 
expected to shed more than 36 000 jobs last year and 
that by 2010-1 it will have 3200 more consultants than 
it can afford to employ.16 
Evidence on good value for money
financial data
In an assessment of wave 1, the Department of Health 
refused to provide the Health Committee with finan-
cial information on private sector contracts and to sup-
ply the methodology underpinning value for money 
on the grounds of commercial confidentiality.9
In a supplementary written submission to the Health 
Committee, the department stated that value for money 
for private centres is calculated in relation to an “NHS 
equivalent cost.” But the cash components of this equiva-
lent cost have not been made public. The then secretary 
of state for health Patricia Hewitt stated that the average 
premium for private treatment centres is 11% above the 
NHS tariff.17 Centres also receive a subsidy (“premium”) 
to cover costs, such as bidding costs, incurred as private 
providers, but the actual amount is unclear. 
risk transfer
Risk transfer is a crucial element in value for money 
analysis of outsourced service contracts. When delays 
prevented private healthcare provider Capio from 
opening an independent sector treatment centre on 
time, Oxfordshire Primary Care Trust still had to pay 
Capio £1m for patients they should have treated in 
the delay period.18
Another key risk—that of clinical negligence claims—
was assumed by private centres in wave 1 contracts 
but was transferred back to the public sector in July 
2004. It was reported that insurance premiums for 
clinical negligence formed a large part of procedure 
Procedures carried out by independent sector treatment centres to April 2007: cumulative totals 
Type of procedure
To 31 December 
20055
To 30 April  
200620
To January  
200721
To 30 April  
20076
Secondary care
Elective procedures 44 000 59 960 107 000 167 850
Diagnostic 
procedures
9 000 25 151 60 000 307 435
All procedures 53 000 85 111 167 000 475 285
Primary care
All procedures 11 679 140 485
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prices for private centres and that the change involved 
“significant” savings,19 but the scale of the savings and 
who benefits have not been made public.
Demand risk and performance against contract
Demand risk, the risk to independent centres that 
fewer procedures than expected would be performed, 
was retained by the NHS from the outset. First wave 
contracts require the contracting primary care trust to 
pay independent centres for all procedures contracted 
for, whether or not they are carried out.9 Evidence 
of underperformance on private contracts, which 
increases NHS costs, is also accruing.
The Commercial Directorate has a separate report-
ing system for private centres. Phase 1 contractual data 
to the end of September 2007, finally published on 
the Department of Health treatment centre website, 
claim 84% contract utilisation so far, with a total of 
293 068 contracted diagnostics and 719 627 contracted 
procedures, broken down by individual contract. But 
these data do not conform to standard NHS report-
ing requirements and are not useful. We do not know 
what procedures were done or the cost or quality of the 
procedures, so we cannot gauge performance, produc-
tivity, or value for money. Furthermore, on the basis of 
the available data, independent centres performed far 
fewer than the annual 170 000 procedures contracted 
for, and two thirds of the total procedures were unspeci-
fied diagnostic procedures such as blood tests, radio-
graphs, or scans—not surgical procedures (table). 
Discussion
The Department of Health has failed to collect and 
provide data to allow evaluation of its policy of using 
for-profit commercial companies to deliver clinical 
services from NHS funds. One member of the Com-
mons Health Committee remarked that the whole area 
seemed to be an evidence-free policy zone.22 The fail-
ure to require independent sector treatment centres—
which treat NHS patients—to provide data on the same 
basis as the NHS raises serious accountability issues. 
So too does government failure to collect and publish 
relevant data on the productivity, performance, and 
quality of these centres. Its refusal to provide data on 
the value for money of independent sector treatment 
centres is worrying, given that recent evaluations of 
Europe-wide attempts to improve health system effi-
ciency by introducing consumer choice through mar-
ket competition found no concrete evidence that the 
introduction or extension of choice “works.”23
In July 2004, a report commissioned by the Depart-
ment of Health commercial directorate concluded that 
without contracts for at least a further 450 000 pro-
cedures a year, the private treatment centre market 
would “stagnate and eventually collapse.”24 Although 
the phase 2 programme, which was to incorporate 24 
schemes has been reduced to 15, the value of the £4bn 
contracts announced in 2005 has not changed.25 While 
it is not possible to know what work private  centres 
have been paid to do, the Healthcare Commission 
report showed that the government is also including 
140 485 primary care procedures in the independent 
sector treatment centre data, even though primary 
care was not part of their initial contract.
Alan Johnson has declared that new private treat-
ment centres will be established only with local agree-
ment and if they provide value for money.26 Value 
for money turns on risk transfer but the available evi-
dence suggests that the real risks are being retained 
by patients, the public, and the NHS. The former 
secretary of state John Reid made a similar declaration 
in September 2003,27 but some private centres were 
imposed on local primary care trusts, with little or 
no consultation with NHS staff or community repre-
sentatives, and sometimes despite strong opposition.9 
Department of Health policy statements stress that 
strategic health authorities will be judged according 
to their primary care trusts’ success in contracting with 
private providers.17 In contrast, in Wales and Scotland 
NHS funds will not be used to enable private provid-
ers to compete with the NHS.28 29
Alan Johnson continues to provide new guarantees 
to the private sector. He recently announced that he 
will create a forum for independent sector providers to 
advise the department on local procurement practice; 
extend the NHS indemnity cover to non-NHS provid-
ers of NHS services; promote patient choice and make 
patients more aware that they can be seen by private 
sector providers free of charge; and continue to use 
the independent sector to help improve primary care 
services and provide additional general practitioner 
surgeries.30
SuMMArY PoINtS
Using NHS funds to deliver 
NHS clinical services via 
the private sector lacks 
evidence and has not 
been evaluated
Data to support 
government claims that 
independent sector 
treatment centres offer 
high productivity, high 
quality health care, or value 
for money are lacking
Such centres are meant 
to provide extra capacity 
and staff, but 23 000 
NHS beds in England 
have closed and many 
NHS clinical staff have 
transferred to the 
private sector since their 
introduction
Patients’, lawyers’, and 
professional bodies’ 
concerns over quality and 
safety are being ignored 
by government
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The recent announcement by the Department of 
Health of the framework contract under which 14 
private sector companies including Bupa, Tribal, and 
United may manage up to 70% of the total NHS 
budget for care, combined with the current roll out 
of contracts to commercial companies such as Vir-
gin and Atos for primary care and general practice, 
shows the strength of the government’s determina-
tion to privatise the delivery of NHS health care.31 
The department has put in place a platform of pri-
vate providers that will enable this to happen. As 
the BMA reported to the Health Committee, “the 
independent sector treatment centre programme 
has developed well beyond the original undertak-
ing to provide additional capacity and instead will 
see large volumes of activity and staff transferred . . . 
to the private sector.”5
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Some readers may be familiar with Ash Wednesday, when mem-
bers of the Roman Catholic community in Northern Ireland have 
charcoal placed on their foreheads as symbolic of the beginning of 
Lent. As time has gone by, this has become an overt statement of 
allegiance in certain areas.
I was working at a hospital when one such patient arrived with a huge 
mark on his forehead. After his eye examination, I wiped down the slit 
lamp and called the next patient for review of his retinal symptoms. His 
tattoos, football shirt, and lack of ash, made it clear he was from a different 
community. 
The retinal check finished, I started to tell the patient that all was well. I 
was horrified to realise that I had forgotten to wipe down the headrest before 
examining him. A heavy handed priest had put so much ash on the previous 
patient that it had transferred to the head rest and now sat resplendent on 
the head of my Protestant patient identifying him to all as a member of a 
different community.
What was I to do? The situation could turn nasty if he saw himself in 
a mirror or if family members in the waiting room saw this “conversion.” 
Other patients’ banter could easily lead into chaos. Thankfully the man 
had fluorescein dye around his eyes so, under the guise of wiping this 
off, I succeeded in wiping his forehead clean.
Obviously one learning point is to clean slit lamps properly between 
patients. More importantly, we must be alert to the sensitivities of the 
communities we serve. Having been brought up in Northern Ireland, I 
was aware of the connotations and potential upset such a simple matter 
could cause. I wonder if doctors from the UK mainland or of other 
nationalities would have been so aware.
Our medical skills offer each of us a passport all over the world, but 
we should temper our universality by considering the traditions of the 
population we work for.
David lockington ophthalmologist, Royal Victoria Hospital, Belfast 
davidlockington@hotmail.com
Ashes to ashes
